Wegovy 2.4mg Injection Pen

Description

Wegovy 2.4mg pen is a semaglutide-based GLP-1 injection used for long-term weight management in adults with obesity or overweight conditions. It represents the final dosage stage in the Wegovy treatment plan, providing the full therapeutic effect of GLP-1 receptor activation for appetite regulation and body weight reduction.

Key Features:

• Highest Wegovy dosage (2.4mg) for advanced treatment

• Once-weekly injection for convenience and consistency

• Clinically proven to aid significant, sustained weight loss (NEJM study)

• Supports appetite suppression and improved metabolic control

How To Use Wegovy 2.4mg Pen:

• Administer once weekly, on the same day and time

• Inject subcutaneously in the abdomen, thigh, or upper arm

• Typically used after completing lower-dose Wegovy stages (0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg) under medical supervision

Side Effects:

Common mild effects: nausea, vomiting, diarrhea, and fatigue. These symptoms often decrease over time. For detailed information, refer to the FDA Wegovy Safety Guide.

Storage Instructions:

• Store in a refrigerator (36°F–46°F / 2°C–8°C)

• Keep capped when not in use

• Do not freeze or expose to heat/light